Use access key #2 to skip to page content.
$0.25 -0.01 (-3.85%)
7/24/2008 9:30 AM

Zila, Inc. (ZILA)

CAPS Rating:
No stars

The Company is a specialty pharmaceutical company focused on the prevention and treatment of oral cancer.

View All Commentary (ZILA)

Recs

1

Avatar souptonutz (< 20) Submitted: 9/22/06 6:26 AM : Outperform Start Price: $2.24 ZILA Score: -85.59

Oral test product (for cancer) is about to launch. It has this (huge) market pretty much to itself.
And the shares have been beaten down.

Report this Post Replies: 1 | Reply

Avatar 1poorguy (97.81) Submitted: 9/22/06 4:09 PM

Recs: 0 | Rec This

They've been claiming toludine blue was ready for years. Did they finally get the FDA to accept it? I haven't seen anything about it, but maybe I missed it.

Report this Post Reply

Featured Broker Partners